Why high-risk patients aren’t getting anti-COVID drugs

As the toll from the COVID-19 pandemic continued to mount, antiviral medications such as Paxlovid were hailed by health officials as an important way to reduce the risk of severe illness or death. Yet the drugs have remained underused, studies have found. In Boston, a group of researchers wanted to […] Read More